Product Information
FLUPHENAZINE 5 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.1482 per EA under NDC 27241025301. Its NADAC has been published 123 times since May 29, 2024.
FDA first approved this application on Jan 5, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241025301
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUPHENAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217410FDA Approved
1/5/2023
TE Code
AB
On Market Since
1/5/2023
Pharmacological Classes
Price Statistics
The NADAC for FLUPHENAZINE 5 MG TABLET has been published 123 times since May 29, 2024, and over the history we have for it it has declined 70.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1482 per EA |
|---|---|
| All-time high | $0.7724 (Aug 14, 2024) |
| All-time low | $0.1213 (Aug 19, 2026) |
| 52-week high | $0.4371 |
| 52-week low | $0.1213 |
| Median price | $0.4032 |
| Average price | $0.4026 |
| Largest weekly change | -52.2% (Aug 21, 2024) |
| Weeks tracked | 123 |
| Tracking since | May 29, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Fluphenazine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ajanta Pharma USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluphenazine hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUPHENAZINE 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLUPHENAZINE 5 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $0.1482 per EA (NDC 27241025301), effective Sep 30, 2026.
How has the price of FLUPHENAZINE 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLUPHENAZINE 5 MG TABLET has declined 70.5%. It has been tracked across 123 weekly CMS publications since May 29, 2024.
What are the highest and lowest recorded NADAC prices for FLUPHENAZINE 5 MG TABLET?
Since May 29, 2024, the NADAC for FLUPHENAZINE 5 MG TABLET has ranged from a low of $0.1213 (Aug 19, 2026) to a high of $0.7724 (Aug 14, 2024), with a median of $0.4032 per EA.
Are there cheaper alternatives to FLUPHENAZINE 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FLUPHENAZINE 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLUPHENAZINE 5 MG TABLET?
FLUPHENAZINE 5 MG TABLET (NDC 27241025301) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.